Low incidence of flare and persistent active disease in a cohort of Italian patients with systemic lupus erythematosus: Comment on the article by Nikpour et al

Arthritis Care and Research

Volumn 62, Issue 6, 2010, Pages 899-900

  Conti, Fabrizio ^a   Ceccarelli, Fulvia ^a   Perricone, Carlo ^a   Massaro, Laura ^a   Spinelli, Francesca Romana ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY;

BLOOD SAMPLING; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; IMMUNOFLUORESCENCE; INCIDENCE; ITALY; LETTER; PROTEIN URINE LEVEL; RENAL SYSTEM PARAMETERS; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 77953087347     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20145     Document Type: Letter

References (4)

1. Nikpour M, Urowitz MB, Ibanez D, Gladman DD. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus. Arthritis Rheum 2009;61: 1152-1158
2. Gladman DD, Ibanez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 2002;29:288-291
3. Mosca M, Bencivelli W, Vitali C, Carrai P, Neri R, Bombardieri S. The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus 2000;9:445-450 (Pubitemid 30487428)
4. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-813 (Pubitemid 27199995)